F2G-33295-27937
4 vaccinations
4 coded responses
41 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 921 / CA
- Registered
- 2021-02-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-01
Registered in v-safe
-
2021-02-01
Dose 1 — Moderna
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-08
-
2021-02-15
Survey response — day 14, dose 1MedDRA: Erythema, Pruritus, Swelling — Feeling: GoodFree text: Vaccine location got red and itchy and slightly swollen 7 days after shot (evening of the day I did my last daily check-in reporting no symptoms). Resolved after 24-36 hours.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-22
- 2021-03-01
- 2021-03-08
-
2021-03-09
Dose 2 — Moderna
- 2021-03-15
- 2021-03-16
- 2021-03-23
- 2021-03-30
- 2021-04-06
- 2021-04-13
- 2021-04-20
- 2021-06-08
- 2021-09-07
-
2021-10-29
Dose 3 — Moderna
-
2021-10-30
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
- 2021-10-31
- 2021-11-01
- 2021-11-02
- 2021-11-03
- 2021-11-04
- 2021-11-05
- 2021-11-12
- 2021-11-19
- 2021-11-26
- 2021-12-03
- 2021-12-10
-
2022-01-28
Survey response — 3 months, dose 3MedDRA: Dyspnoea, Fatigue, Headache, Respiratory tract congestion, Sneezing — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Headache, congestion, sneezing, shortness of breath, fatigueMedDRA releases: 2024-11 · check-in free text available
-
2022-04-05
Dose 4 — Moderna
- 2022-04-15
-
2022-04-19
Survey response — day 14, dose 4MedDRA: Chest pain, Dyspnoea, Office visit — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Shortness of breath and mild chest pain · Healthcare visit (other): In person dr. VisitMedDRA releases: 2024-11 · check-in free text available
-
2022-04-19
Report sent to call center — day 14, dose 4Get care from a doctor or other healthcare professional1 call case(s)
- 2022-04-21
- 2022-05-05
- 2022-05-10
-
2022-05-17
Survey response — day 42, dose 4MedDRA: Cough, Fatigue, Headache, Pyrexia, SARS-CoV-2 test positive, Unevaluable event — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: I have had Covid for the past week. Tested positive 5/11/22 and had fever, cough, headache, fatigue until yesterday. Still fatigued and testing positive but otherwise better. · Healthcare visit (other): PaxlovidMedDRA releases: 2024-11 · check-in free text available
-
2022-05-17
Report sent to call center — day 42, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-05-18
- 2022-05-18
-
2022-05-23
Call successfulCompleted over the phone
- 2022-07-05
- 2023-04-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-01 | Moderna | |
| 2 | 2021-03-09 | Moderna | |
| 3 | 2021-10-29 | Moderna | No |
| 4 | 2022-04-05 | Moderna | No |
Call center
2 call center cases
1 successful · 1 unsuccessful
VAERS report filed, before or during a call: 1
Free text
Release 4 — day 14, dose 1
Symptoms: Vaccine location got red and itchy and slightly swollen 7 days after shot (evening of the day I did my last daily check-in reporting no symptoms). Resolved after 24-36 hours.
Release 11 — 3 months, dose 3
Symptoms: Headache, congestion, sneezing, shortness of breath, fatigue
Release 11 — day 14, dose 4
Symptoms: Shortness of breath and mild chest pain
Healthcare visit (other): In person dr. Visit
Release 11 — day 42, dose 4
Symptoms: I have had Covid for the past week. Tested positive 5/11/22 and had fever, cough, headache, fatigue until yesterday. Still fatigued and testing positive but otherwise better.
Healthcare visit (other): Paxlovid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Chest pain | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Erythema | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Pruritus | ✓ | ✓ | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SD | Swelling | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release